Atlas FDA

Radiesse Injectable Implant

FDA premarket approval P050037/S111 · decided 2021-06-08

Approval details

PMA number
P050037
Supplement
S111
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Radiesse Injectable Implant
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2020-12-23
Decision date
2021-06-08
Days to decision
167 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Approval for the change in mixing the gel and media in a larger mixing bowl rather than multiple smaller mixing bowls during manufacturing of Radiesse Injectable Implant.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29